FERRARI LOUIS 4
4 · SAVIENT PHARMACEUTICALS INC · Filed Nov 27, 2012
Insider Transaction Report
Form 4
FERRARI LOUIS
SVP, North American Commerical
Transactions
- Award
Common Stock, $.01 par value per share
2012-02-29$1.71/sh+2,622$4,480→ 351,199 total - Award
Common Stock, $.01 par value per share
2012-08-31$1.12/sh+2,434$2,731→ 359,521 total - Award
Common Stock, $.01 par value per share
2012-05-31$0.62/sh+5,888$3,625→ 357,087 total - Sale
Common Stock, $.01 par value per share
2012-11-26$1.16/sh−950$1,102→ 358,571 total
Footnotes (2)
- [F1]Consists of shares acquired pursuant to the Savient Pharmaceuticals, Inc. 1998 Employee Stock Purchase Plan, which were not previously reported on a Form 4.
- [F2]These shares were sold automatically pursuant to a binding contract under Rule 10b5-1 of the Securities Exchange Act of 1934 to cover tax withholding obligations in connection with the vesting of restricted stock granted on February 21, 2011.